REMED CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,560 KRW | +2.01% |
|
+4.86% | +9.37% |
| Sales 2022 | 21.36B 15.49M | Sales 2023 | 18.54B 13.44M | Capitalization | 99.73B 72.3M |
|---|---|---|---|---|---|
| Net income 2022 | 4B 2.9M | Net income 2023 | 797M 578K | EV / Sales 2022 | 3.02 x |
| Net cash position 2022 | 11.07B 8.03M | Net Debt 2023 | 12.06B 8.74M | EV / Sales 2023 | 6.03 x |
| P/E ratio 2022 |
42
x | P/E ratio 2023 |
125
x | Employees | 100 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.8% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.01% | ||
| 1 week | +4.86% | ||
| Current month | +4.86% | ||
| 1 month | +20.68% | ||
| 3 months | +25.35% | ||
| 6 months | +6.59% | ||
| Current year | +9.37% |
1 week
3 250.00
3 575.00
1 month
3 250.004 065.00
Current year
2 545.004 065.00
1 year
2 545.004 500.00
3 years
2 030.006 900.00
5 years
2 030.007 910.00
10 years
2 030.007 910.00
| Managers | Title | Age | Since |
|---|---|---|---|
Eun-Hyun Go
CEO | Chief Executive Officer | 61 | 16-10-31 |
Jung-Soo Lee
DFI | Director of Finance/CFO | 58 | 21-01-31 |
Sang-Yong Lee
PSD | President | 54 | 16-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Geun-Yong Lee
CHM | Chairman | 56 | 03-06-30 |
Sung-Pil Hong
BRD | Director/Board Member | 56 | - |
Sung-Taek Jung
BRD | Director/Board Member | 55 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 3,560 | +2.01% | 117,536 |
| 24-06-05 | 3,490 | +3.25% | 73,282 |
| 24-06-04 | 3,380 | -3.43% | 151,372 |
| 24-06-03 | 3,500 | +3.09% | 137,825 |
| 24-05-31 | 3,395 | -3.96% | 91,053 |
End-of-day quote Korea S.E., June 06, 2024
More quotes
REMED Co., Ltd. is a Korea-based company mainly engaged in the production and sale of medical equipments. The Company is involved in the manufacturing and sale of transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, electrosurgical units as well as biosignal and monitoring machines. The pain therapy machines include electromagnetic stimulation machines, extracorporeal shockwave therapy machines and high intensity laser therapy machines, among others. The biosignal and monitoring machines include patient monitors, fetal monitors, electrocardiogram (ECG/EKG) machines, among others. The Company distributes its products within the domestic market and to overseas markets.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.37% | 79.15M | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +4.75% | 66.45B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B | |
| +22.61% | 30.98B |
- Stock Market
- Equities
- A302550 Stock
